. 2020 Jul 24;11(4):1020–1076. doi: 10.1111/jdi.13306

Table 11.

Glycemic control targets for pregnant women ⁸ , ⁹ , ¹⁶ , ¹⁷

	Japan Diabetes Society (JDS)	American Diabetes Association (ADA)	National Institute for Health and Care Excellence (NICE)
Fasting plasma glucose (FPG)	<95 mg/dL*¹	<95 mg/dL	<5.3 mmol/L*⁴ (<95 mg/dL)
Postprandial plasma glucose (PPG)	1‐h PPG <140 mg/dL Or 2‐h PPG <120 mg/dL	1‐h PPG <140 mg/dL Or 2‐h PPG <120 mg/dL	1‐h PPG <7.8 mmol/L (<140 mg/dL) Or 2‐h PPG <6.4 mmol/L (115 mg/dL)
HbA1c	<6.0–6.5%*²	<6.0%*³	<6.5%

Japan Diabetes Society (JDS)

American Diabetes Association (ADA)

National Institute for Health and Care Excellence (NICE)

Fasting plasma glucose (FPG)

<95 mg/dL*¹

<95 mg/dL

<5.3 mmol/L*⁴

(<95 mg/dL)

Postprandial plasma glucose (PPG)

1‐h PPG <140 mg/dL

2‐h PPG <120 mg/dL

1‐h PPG <140 mg/dL

2‐h PPG <120 mg/dL

1‐h PPG <7.8 mmol/L

(<140 mg/dL)

2‐h PPG <6.4 mmol/L

(115 mg/dL)

HbA1c

<6.0–6.5%*²

<6.0%*³

<6.5%

*1 In patients at high risk of severe hypoglycemia, such as hypoglycemia unawareness, consideration is to be given to measuring blood glucose at different time points and to relaxing the glycemic control targets.

*2 Given that HbA1c is subject to the influence of iron metabolism in pregnant women, priority should be given to self‐monitoring of blood glucose (SMBG)‐based targets for glycemic control in these women. Again, the HbA1c target is to be individually determined for each pregnant woman, which vary depending on her gestational age (weeks) and risk of hypoglycemia.

*3 HbA1c control targets may be relaxed and set at <7.0% to avoid onset of hypoglycemia for pregnant women in whom hypoglycemia is an issue.

*4 Care is to be given to ensuring that FPG is maintained at >4.0 mmol/L (72 mg/dL) in women receiving insulin therapy.